Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.

    Ryan SL, Schwalbe EC, Cole M, Lu Y, Lusher ME, Megahed H, O'Toole K, Nicholson SL, Bognar L, Garami M, Hauser P, Korshunov A, Pfister SM, Williamson D, Taylor RE, Ellison DW, Bailey S, Clifford SC.

    Acta Neuropathol. 2012 Apr;123(4):501-13. doi: 10.1007/s00401-011-0923-y. Epub 2011 Dec 3.

    PMID:
    22139329
    [PubMed - in process]
    2.

    Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors.

    Walker EJ, Zhang C, Castelo-Branco P, Hawkins C, Wilson W, Zhukova N, Alon N, Novokmet A, Baskin B, Ray P, Knobbe C, Dirks P, Taylor MD, Croul S, Malkin D, Tabori U.

    Cancer Res. 2012 Feb 1;72(3):636-44. Epub 2011 Dec 5.

    PMID:
    22144470
    [PubMed - indexed for MEDLINE]
    3.

    Classifying human brain tumors by lipid imaging with mass spectrometry.

    Eberlin LS, Norton I, Dill AL, Golby AJ, Ligon KL, Santagata S, Cooks RG, Agar NY.

    Cancer Res. 2012 Feb 1;72(3):645-54. Epub 2011 Dec 2.

    PMID:
    22139378
    [PubMed - indexed for MEDLINE]
    4.

    Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.

    Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, Wick W, Pietsch T, Loeffler M, Weller M; for the German Glioma Network.

    Int J Cancer. 2011 Dec 3. doi: 10.1002/ijc.27385. [Epub ahead of print]

    PMID:
    22139906
    [PubMed - as supplied by publisher]
    5.

    Spot scanning-based proton therapy for intracranial meningioma: long-term results from the paul scherrer institute.

    Weber DC, Schneider R, Goitein G, Koch T, Ares C, Geismar JH, Schertler A, Bolsi A, Hug EB.

    Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):865-71. Epub 2011 Dec 2.

    PMID:
    22138457
    [PubMed - in process]
    6.

    Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas-clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.

    Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A, Debus J, Combs SE.

    Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):859-64. Epub 2011 Dec 2.

    PMID:
    22137023
    [PubMed - in process]
    7.

    Unrecognized visual field deficits in children with primary central nervous system brain tumors.

    Harbert MJ, Yeh-Nayre LA, O'Halloran HS, Levy ML, Crawford JR.

    J Neurooncol. 2012 May;107(3):545-9. Epub 2011 Dec 4.

    PMID:
    22139448
    [PubMed - in process]
    8.

    Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria.

    Radbruch A, Lutz K, Wiestler B, Bäumer P, Heiland S, Wick W, Bendszus M.

    Neuro Oncol. 2012 Feb;14(2):222-9. Epub 2011 Dec 6.

    PMID:
    22146386
    [PubMed - indexed for MEDLINE]
    9.

    EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.

    Bonavia R, Inda MM, Vandenberg S, Cheng SY, Nagane M, Hadwiger P, Tan P, Sah DW, Cavenee WK, Furnari FB.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.563. [Epub ahead of print]

    PMID:
    22139077
    [PubMed - as supplied by publisher]
    10.

    MiR-135a functions as a selective killer of malignant glioma.

    Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y, Zhu W, Su X, Zhou Y, Qiu P, Yan G.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.551. [Epub ahead of print]

    PMID:
    22139076
    [PubMed - as supplied by publisher]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk